Clinical Trial Update: Ascending Single Dose Study of Rhu-pGelsolin in Patients With Decreased Gelsolin Levels [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for an ascending single-dose study of recombinant human gelsolin (Rhu-pGelsolin) in patients with decreased gelsolin levels due to trauma,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burns
• Infection
• Trauma

Drugs mentioned

• Rhu-pGelsolin (recombinant human gelsolin)

Snippet

Sponsor: Critical Biologics Corporation | Conditions: Low Gelsolin, Trauma | Phase 1, Phase 2 | Status: COMPLETED